Literature DB >> 2297817

Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia.

G D Lopaschuk1, M A Spafford, N J Davies, S R Wall.   

Abstract

Alterations in energy substrate utilization during reperfusion of ischemic hearts can influence the functional recovery of the myocardium. Energy substrate preference by the reperfused myocardium, however, has received limited attention. Therefore, we measured oxidation rates of glucose and palmitate during reperfusion of ischemic hearts. Isolated working rat hearts were perfused with 1.2 mM palmitate and 11 mM [14C]glucose, 1.2 mM [14C]palmitate and 11 mM glucose, or 11 mM [14C]glucose alone, at an 11.5 mm Hg preload and 80 mm Hg afterload. Hearts were subjected to 60-minute aerobic perfusion or 25-minute global ischemia followed by 60-minute aerobic reperfusion. Steady-state oxidative rates of glucose or palmitate were determined by measuring 14CO2 production. In hearts perfused with glucose alone, oxidative rates during reperfusion were not significantly different than nonischemic hearts (1,008 +/- 335 vs. 1,372 +/- 117 nmol [14C]glucose oxidized/min/g dry wt, respectively). In the presence of palmitate, glucose oxidation was markedly reduced in reperfused and nonischemic hearts (81 +/- 11 and 101 +/- 15 nmol [14C]glucose oxidized/min/g dry wt, respectively). Palmitate oxidation rates were not significantly different in reperfused compared with nonischemic hearts (369 +/- 55 and 455 +/- 50 nmol [14C]palmitate oxidized/min/g dry wt, respectively). [14C]Palmitate was incorporated into myocardial triglycerides to a greater extent in reperfused ischemic hearts than in nonischemic hearts (26.0 and 13.8 mumol/g dry wt, respectively). Under the perfusion conditions used, palmitate provided over 90% of the ATP produced from exogenous substrates. Addition of the carnitine palmitoyltransferase I inhibitor, ethyl 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (Etomoxir, 10(-6) M), during reperfusion stimulated glucose oxidation and improved mechanical recovery of ischemic hearts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297817     DOI: 10.1161/01.res.66.2.546

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  54 in total

Review 1.  Myocardial fatty acid oxidation during ischemia and reperfusion.

Authors:  R Lerch; C Tamm; I Papageorgiou; R H Benzi
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

2.  Is BMIPP a sensitive marker for myocardial ischaemic stress? Against.

Authors:  Robert J Gropler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-27       Impact factor: 9.236

3.  Epinephrine-stimulated contractile and metabolic reserve in postischemic rat myocardium.

Authors:  G Görge; I Papageorgiou; R Lerch
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

Review 4.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

5.  Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart.

Authors:  J Michael O'Donnell; Nathaniel M Alpert; Lawrence T White; E Douglas Lewandowski
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

6.  Glucose is essential for the initiation of fatty acid oxidation in ATP-depleted cultured ventricular myocytes.

Authors:  R Tirosh; T Mishor; A Pinson
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

Review 7.  Advantages and limitations of experimental techniques used to measure cardiac energy metabolism.

Authors:  G D Lopaschuk
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

8.  Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3-.

Authors:  Matthew E Merritt; Crystal Harrison; Charles Storey; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

Review 9.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

10.  Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study.

Authors:  Marie A Schroeder; Pawel Swietach; Helen J Atherton; Ferdia A Gallagher; Phillip Lee; George K Radda; Kieran Clarke; Damian J Tyler
Journal:  Cardiovasc Res       Date:  2009-12-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.